tirzepatide and dementia Could a diabetes drug be the key to stopping Alzheimer's? Semaglutide and Tirzepatide Cut Dementia

This consistent cadence of care is what transforms a prescription into a true partnership between you and your medical team

Building India's first messaging unicorn

Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has become a cornerstone of modern weight management therapy

This could signal a future where a common diabetes drug plays a big role in brain health and even dementia prevention. This is especially important to note for women and people assigned female at birth (AFAB) since Alzheimers is more common in women than men

Reasonable candidates are patients already engaged in a supervised weight-loss programme with diet and activity in place, who understand it is adjunctive

Semaglutide and lisinopril are two medicines that help people manage their health in different ways